Get the Stockscreener App
198.14
0.24%
-0.47
After Hours:
198.14
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $198.14, with a volume of 3.18M.
It is down -0.24% in the last 24 hours and up +5.78% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$198.61
Open:
$199.05
24h Volume:
3.18M
Relative Volume:
0.78
Market Cap:
$140.22B
Revenue:
$24.57B
Net Income/Loss:
$3.60B
P/E Ratio:
39.23
EPS:
5.051
Net Cash Flow:
$5.26B
1W Performance:
+0.99%
1M Performance:
+5.78%
6M Performance:
-3.86%
1Y Performance:
+4.33%
1-Day Range:
$197.28
$199.48
1-Week Range:
$188.06
$200.40
52-Week Range:
$180.03
$242.80
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
198.14 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
531.67 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
580.76 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
119.77 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
326.20 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
SeaBridge Investment Advisors LLC Takes Position in Danaher Corporation $DHR - MarketBeat
What to expect from Danaher Corporation's Q1 2026 earnings report - MSN
Danaher Corp. stock (US2358511028): Why does its business model matter more now for long-term invest - AD HOC NEWS
15,141 Shares in Danaher Corporation $DHR Purchased by Annex Advisory Services LLC - MarketBeat
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration - PR Newswire
Danaher Corp. stock (US2358511028): Is its life sciences moat strong enough to unlock new upside? - AD HOC NEWS
DHR Maintained by Barclays -- Price Target Lowered to $230 - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
TD Cowen Issues Pessimistic Forecast for Danaher (NYSE:DHR) Stock Price - MarketBeat
Norris Perne & French LLP MI Boosts Stake in Danaher Corporation $DHR - MarketBeat
JM2 Capital Inc. Takes $1.33 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher (DHR) Projected to Post Earnings on Tuesday - MarketBeat
Danaher Corp (DHR) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
DHR Maintained by Goldman Sachs -- Price Target Lowered to $230 - GuruFocus
The Goldman Sachs Group Lowers Danaher (NYSE:DHR) Price Target to $230.00 - MarketBeat
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes - PR Newswire
Best Biotech Stocks To Keep An Eye OnApril 12th - MarketBeat
Sumitomo Mitsui Trust Group Inc. Cuts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
Biotech Stocks To ResearchApril 11th - MarketBeat
Massachusetts Financial Services Co. MA Boosts Stake in Danaher Corporation $DHR - MarketBeat
Factory Mutual Insurance Co. Sells 5,500 Shares of Danaher Corporation $DHR - MarketBeat
Bar Harbor Wealth Management Has $14.72 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Promising Biotech Stocks To Follow TodayApril 10th - MarketBeat
GENERAL AMERICAN INVESTORS CO INC's Danaher Corp(DHR) Holding History - GuruFocus
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Douglas Lane & Associates LLC Grows Position in Danaher Corporation $DHR - MarketBeat
Market news - investments.halifax.co.uk
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Published on: 2026-04-10 13:38:44 - baoquankhu1.vn
Danaher Corporation (DHR) stock price, news, quote and history - Yahoo Finance UK
Masimo stock price target raised to $180 by Jefferies on Danaher deal - Investing.com Australia
Danaher Corporation $DHR Stock Holdings Cut by CCLA Investment Management - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
The Osterweis Fund's Danaher Corp(DHR) Holding History - GuruFocus
Support Test: Whats the beta of Danaher Corporation stockQuarterly Trade Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Biotech Stocks To Keep An Eye OnApril 8th - MarketBeat
Danaher Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape - Markets Mojo
Danaher (NYSE:DHR) Given New $230.00 Price Target at Wolfe Research - MarketBeat
Jefferies Financial Group Has Lowered Expectations for Danaher (NYSE:DHR) Stock Price - MarketBeat
9,123 Shares in Danaher Corporation $DHR Purchased by Oak Thistle LLC - MarketBeat
Sivik Global Healthcare LLC Trims Stock Holdings in Danaher Corporation $DHR - MarketBeat
GREENWOOD CAPITAL ASSOCIATES LLC's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation $DHR Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Evercore ISI Cuts Danaher (DHR) Price Target, Adds Shares to Tactical Outperform List - Insider Monkey
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):